BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Winzap P, Davies A, Klingenberg R, Obeid S, Roffi M, Mach F, Räber L, Windecker S, Templin C, Nietlispach F, Nanchen D, Gencer B, Muller O, Matter CM, von Eckardstein A, Lüscher TF. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61. Cardiovasc Diabetol 2019;18:142. [PMID: 31672144 DOI: 10.1186/s12933-019-0946-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang W, Zhou Y, Chen S, Liu S. Impact of Chronic Kidney Disease on Outcomes of Percutaneous Coronary Intervention in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis. Tex Heart Inst J 2023;50. [PMID: 36753753 DOI: 10.14503/THIJ-22-7873] [Reference Citation Analysis]
2 Shen J, Feng B, Fan L, Jiao Y, Li Y, Liu H, Hou X, Su Y, Li D, Fu Z. Triglyceride glucose index predicts all-cause mortality in oldest-old patients with acute coronary syndrome and diabetes mellitus. BMC Geriatr 2023;23:78. [PMID: 36747129 DOI: 10.1186/s12877-023-03788-3] [Reference Citation Analysis]
3 Ajjan RA, Heller SR, Everett CC, Vargas-Palacios A, Higham R, Sharples L, Gorog DA, Rogers A, Reynolds C, Fernandez C, Rodrigues P, Sathyapalan T, Storey RF, Stocken DD. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial. Diabetes Care 2023;46:441-9. [PMID: 36516054 DOI: 10.2337/dc22-1219] [Reference Citation Analysis]
4 Li Y, Wang Q, Pei J, Wang X, Zheng K, Zhang P, Yan J. Elevated Glucose on Admission Was an Independent Risk Factor For 30-Day Major Adverse Cardiovascular Events in Patients with STEMI But Not NSTEMI.. [DOI: 10.21203/rs.3.rs-2089245/v1] [Reference Citation Analysis]
5 Mahdavi-Roshan M, Ghorbani Z, Gholipour M, Salari A, Savar Rakhsh A, Kheirkhah J. Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction (LVEF) in patients with ST-elevation myocardial infarction (STEMI). BMC Cardiovasc Disord 2022;22:224. [PMID: 35568801 DOI: 10.1186/s12872-022-02660-3] [Reference Citation Analysis]
6 Jabali MS, Sadeghi M, Nabovati E, Sarrafzadegan N, Farzandipour M. Determination of Characteristics and Data Elements requirements in National Acute Coronary Syndrome Registries for Post-discharge Follow-up. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101244] [Reference Citation Analysis]
7 Babes EE, Bustea C, Behl T, Abdel-Daim MM, Nechifor AC, Stoicescu M, Brisc CM, Moisi M, Gitea D, Iovanovici DC, Bungau AF, Tit DM, Bungau SG. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy. Biomed Pharmacother 2022;148:112772. [PMID: 35245735 DOI: 10.1016/j.biopha.2022.112772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wang P, Yuan D, Zhang C, Zhu P, Jia S, Song Y, Tang X, Xu J, Li T, Zeng G, Zhao X, Yang Y, Xu B, Gao R, Yuan J. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol 2022;21:46. [PMID: 35313877 DOI: 10.1186/s12933-022-01477-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang Y, Wang W, Jia S, Gao M, Zheng S, Wang J, Dang Y, Li Y, Qi X. Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China. BMJ Open 2022;12:e056101. [PMID: 35110324 DOI: 10.1136/bmjopen-2021-056101] [Reference Citation Analysis]
10 Sun L, Guo M, Xu C, Qiao X, Hua Y, Tuerhongjiang G, Lou B, Li R, Bai X, Zhou J, Wu Y, She J, Yuan Z. HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome. Dis Markers 2021;2021:6689056. [PMID: 34055102 DOI: 10.1155/2021/6689056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Pathak AS, Rojas M, Stouffer GA. Expression of Cyr61 in ApoE-/- mice with chronic unilateral renal artery ligation. Sci Rep 2021;11:3606. [PMID: 33574403 DOI: 10.1038/s41598-021-81646-1] [Reference Citation Analysis]
12 Paolisso P, Foà A, Bergamaschi L, Donati F, Fabrizio M, Chiti C, Angeli F, Toniolo S, Stefanizzi A, Armillotta M, Rucci P, Iannopollo G, Casella G, Marrozzini C, Galiè N, Pizzi C. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol 2021;20:33. [PMID: 33530978 DOI: 10.1186/s12933-021-01222-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
13 Hainguerlot S. [Diagnostic value of high-sensitivity troponin I to predict cardiac causes after syncope/near syncope in emergency department]. Ann Cardiol Angeiol (Paris) 2021;70:86-93. [PMID: 33339571 DOI: 10.1016/j.ancard.2020.11.005] [Reference Citation Analysis]
14 Feng B, Xu G, Sun K, Duan K, Shi B, Zhang N. Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes. Cardiovasc Diabetol 2020;19:194. [PMID: 33222686 DOI: 10.1186/s12933-020-01171-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Park SJ, Ha KH, Kim DJ. Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study. Cardiovasc Diabetol 2020;19:191. [PMID: 33172464 DOI: 10.1186/s12933-020-01170-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
16 Lucci C, Cosentino N, Genovese S, Campodonico J, Milazzo V, De Metrio M, Rondinelli M, Riggio D, Biondi ML, Rubino M, Celentano K, Bonomi A, Capra N, Veglia F, Agostoni P, Bartorelli AL, Marenzi G. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus. Cardiovasc Diabetol 2020;19:183. [PMID: 33081810 DOI: 10.1186/s12933-020-01157-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Li M, Duan L, Cai YL, Li HY, Hao BC, Chen JQ, Liu HB. Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease. Cardiovasc Diabetol 2020;19:120. [PMID: 32746821 DOI: 10.1186/s12933-020-01092-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]